Literature DB >> 2839569

Effects of dopamine on left ventricular afterload and contractile state in heart failure: relation to the activation of beta 1-adrenoceptors and dopamine receptors.

S I Rajfer1, K M Borow, R M Lang, A Neumann, J D Carroll.   

Abstract

Although long-term therapy with oral beta-adrenoceptor agonists in patients with heart failure is generally associated with the development of diminished pharmacologic efficacy, the ingestion of levodopa, which is decarboxylated endogenously to dopamine, is associated with a sustained improvement in cardiac function. The beneficial hemodynamic actions of dopamine in patients with heart failure have been attributed to a positive inotropic effect that is mediated through activation of beta 1-adrenoceptors. However, a reduction in left ventricular afterload resulting from the activation of dopamine receptors may also lead to an improvement in the performance of the failing heart. To ascertain the relative importance of the positive inotropic and afterload-reducing effects of dopamine in patients with heart failure, dopamine (2, 4, 6 micrograms/kg per min), dobutamine (2, 6, 10 micrograms/kg per min) and nitroprusside (0.125 to 2.0 micrograms/kg per min) were administered to 13 patients with dilated cardiomyopathy while monitoring left ventricular wall thickness and dimensions by echocardiography and left ventricular and aortic pressures with a micromanometer-tipped catheter. Altering left ventricular afterload, quantified as end-systolic circumferential wall stress, with nitroprusside allowed generation of the left ventricular end-systolic circumferential wall stress-velocity of fiber shortening relation that represented the baseline contractile state of the myocardium. Left ventricular velocity of fiber shortening was elevated during the administration of dobutamine and dopamine when compared with measurements obtained with nitroprusside at the same left ventricular end-systolic circumferential wall stress. Furthermore, left ventricular end-systolic wall stress decreased with dopamine but not with dobutamine. Thus, the beta 1-adrenoceptor activity of dopamine and dobutamine augmented the contractile state of the myocardium.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839569     DOI: 10.1016/0735-1097(88)90426-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  5 in total

Review 1.  Cross interaction of dopaminergic and adrenergic systems in neural modulation.

Authors:  Saobo Lei
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2014-10-11

2.  The use of levodopa, an oral dopamine precursor, in congestive heart failure.

Authors:  G Broderick; S I Rajfer
Journal:  Basic Res Cardiol       Date:  1989       Impact factor: 17.165

3.  Dopaminergic modulation of GABAergic transmission in the entorhinal cortex: concerted roles of α1 adrenoreceptors, inward rectifier K⁺, and T-type Ca²⁺ channels.

Authors:  Nicholas I Cilz; Lalitha Kurada; Binqi Hu; Saobo Lei
Journal:  Cereb Cortex       Date:  2013-07-10       Impact factor: 5.357

4.  Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).

Authors:  Siu-Hin Wan; Susanna R Stevens; Barry A Borlaug; Kevin J Anstrom; Anita Deswal; G Michael Felker; Michael M Givertz; Bradley A Bart; W H Wilson Tang; Margaret M Redfield; Horng H Chen
Journal:  Circ Heart Fail       Date:  2016-08       Impact factor: 8.790

Review 5.  Inpatient Diuretic Management of Acute Heart Failure: A Practical Review.

Authors:  Saif Ali; Sharon Jung; Shuktika Nandkeolyar; Liset Stoletniy; Antoine Sakr; Frederik H Verbrugge; Anthony Hilliard; Dmitry Abramov
Journal:  Am J Cardiovasc Drugs       Date:  2021-03-12       Impact factor: 3.571

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.